News · 26 weeks62+1200%
2026-03-012026-08-23
Mix1990d
- Insider11(58%)
- SEC Filings4(21%)
- Earnings2(11%)
- Analyst1(5%)
- Other1(5%)
Latest news
25 items- PRDaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney DiseaseMore than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizationsDENVER, Aug. 25, 2026 /PRNewswire/ -- DaVita today announced a new value-based care agreement to deliver comprehensive, coordinated care to Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5.Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.As the healthcare system aims for more impactful, value-based, preventive care, DaVita continues to lead in managing complex chronic conditions earlie
- INSIDERDirector Hollar Jason M. was granted 278 shares, increasing direct ownership by 4% to 6,883 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Desoer Barbara J was granted 278 shares (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Pullin Dennis W was granted 278 shares, increasing direct ownership by 10% to 2,949 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Moore Gregory J. was granted 278 shares, increasing direct ownership by 4% to 8,091 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Yale Phyllis R was granted 278 shares, increasing direct ownership by 3% to 9,803 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Schechter Adam H was granted 278 shares, increasing direct ownership by 5% to 5,970 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Schoppert Wendy Lee was granted 278 shares (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Arway Pamela M was granted 278 shares, increasing direct ownership by 1% to 27,223 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- ANALYSTDaVita upgraded by TD Cowen with a new price targetTD Cowen upgraded DaVita from Hold to Buy and set a new price target of $220.00
- SECSEC Form 10-Q filed by DaVita Inc.10-Q - DAVITA INC. (0000927066) (Filer)
- SECDaVita Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - DAVITA INC. (0000927066) (Filer)
- PRDaVita Inc. 2nd Quarter 2026 ResultsDENVER, Aug. 4, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended June 30, 2026."Thanks to the outstanding efforts of our teammates, we had another positive quarter for both patient outcomes and financial results," said Javier Rodriguez, CEO of DaVita Inc. "As we look to the rest of the year, we maintain our strategic focus on exciting new innovations in kidney dialysis to enhance the lives of our patients."Financial and operating highlights for the quarter ended June 30, 2026:Consolidated revenues were $3.554 billion.Operating income was $579 million.Diluted earnings per share was $4.02.Operating cash flow was $490 million and free c
- PRDaVita Inc. Schedules 2nd Quarter 2026 Investor Conference CallDENVER, July 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 4, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Tuesday, August 4, 2026 Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to
- INSIDERChief Legal & Pub. Affairs Off Waters Kathleen Alyce sold $3,210,377 worth of shares (15,405 units at $208.40) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 109,194 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERChief Executive Officer Rodriguez Javier sold $14,532,108 worth of shares (69,407 units at $209.38), decreasing direct ownership by 8% to 840,408 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- SECSEC Form 11-K filed by DaVita Inc.11-K - DAVITA INC. (0000927066) (Filer)
- SECDaVita Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - DAVITA INC. (0000927066) (Filer)
- INSIDERDirector Yale Phyllis R gifted 5,038 shares, decreasing direct ownership by 35% to 9,525 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Pullin Dennis W was granted 250 shares, increasing direct ownership by 10% to 2,671 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Schoppert Wendy Lee was granted 250 shares (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Moore Gregory J. was granted 250 shares, increasing direct ownership by 3% to 7,813 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Arway Pamela M was granted 250 shares, increasing direct ownership by 0.94% to 26,945 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Yale Phyllis R was granted 250 shares, increasing direct ownership by 2% to 14,563 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
- INSIDERDirector Hollar Jason M. was granted 250 shares, increasing direct ownership by 4% to 6,605 units (SEC Form 4)4 - DAVITA INC. (0000927066) (Issuer)
DVA FAQ
6 questionsWhat does DaVita Inc. do?
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease...Where does DVA stock trade?
DaVita Inc. (DVA) is listed on NYSE.What sector and industry is DVA in?
DaVita Inc. operates in the Health Care sector, Misc Health and Biotechnology Services industry.What are analysts saying about DVA?
DaVita Inc. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy on 2026-08-07.What companies are similar to DVA?
Notable peers in the same industry include FMS (Fresenius Medical Care AG), SHC (Sotera Health Company), PGNY (Progyny Inc.), AGL (agilon health inc.), VMD (Viemed Healthcare Inc.). Compare DVA side-by-side with any of them on Quantisnow.How can I track DVA on Quantisnow?
Quantisnow aggregates DaVita Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DVA to receive live email and push alerts on every new disclosure.